DaShenLin Pharmaceutical Group Co., Ltd.
Shanghai Stock Exchange 603233.SS
DaShenLin Pharmaceutical Group Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2023: 0.80
DaShenLin Pharmaceutical Group Co., Ltd. Debt to Equity Ratio is 0.80 for the year ending December 31, 2023, a -16.49% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.
-
DaShenLin Pharmaceutical Group Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2022 was 0.95, a -0.84% change year over year.
-
DaShenLin Pharmaceutical Group Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2021 was 0.96, a 270.56% change year over year.
-
DaShenLin Pharmaceutical Group Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2020 was 0.26, a 234.57% change year over year.
-
DaShenLin Pharmaceutical Group Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2019 was 0.08, a -33.13% change year over year.
Key data
| Date | Debt to Equity Ratio | Debt to Income Ratio | Debt to Tangible Net Worth Ratio | Dividend Coverage Ratio |
|---|
Market news
Loading...
Shanghai Stock Exchange: 603233.SS
| CEO | Mr. Guoqiang Ke |
| IPO Date | July 31, 2017 |
| Location | China |
| Headquarters | 410 Longxi Avenue |
| Employees | 45,466 |
| Sector | Health Care |
| Industries | |
Description
DaShenLin Pharmaceutical Group Co., Ltd. manufactures, wholesales, and retails pharmaceutical products in China. The company was founded in 1999 and is based in Guangzhou, China.
Key trends
Past 5 years
Similar companies
Shanghai M&G Stationery Inc.
USD 3.92
1.92%
Yifeng Pharmacy Chain Co., Ltd.
USD 3.33
0.92%
Autobio Diagnostics Co., Ltd.
USD 5.54
1.35%
LBX Pharmacy Chain Joint Stock Company
USD 2.19
4.03%
Asymchem Laboratories (Tianjin) Co., Ltd.
USD 10.09
5.71%
StockViz Staff
January 15, 2025
Any question? Send us an email